<!DOCTYPE html>
<html lang="en">

<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Lesson 11.5: Adverse Event Reporting and Clinical Documentation</title>
    <style>
        /* Base & Reset */
        * {
            box-sizing: border-box;
        }

        body {
            font-family: Georgia, 'Times New Roman', serif;
            line-height: 1.8;
            color: #2d2d2d;
            background: #f8f6f3;
            margin: 0;
            padding: 0;
        }

        /* Main Container */
        .lesson-container {
            max-width: 860px;
            margin: 0 auto;
            padding: 40px 30px;
            background: #ffffff;
            min-height: 100vh;
            box-shadow: 0 0 60px rgba(0, 0, 0, 0.08);
        }

        /* Brand Header */
        .brand-header {
            text-align: center;
            padding-bottom: 30px;
            margin-bottom: 35px;
            border-bottom: 1px solid #eee;
        }

        .brand-logo {
            max-width: 220px;
            height: auto;
            margin-bottom: 5px;
        }

        /* Module Header - RED/Safety theme for Toxicology */
        .module-header {
            background: linear-gradient(135deg, #7f1d1d 0%, #b91c1c 100%);
            padding: 35px 35px 30px;
            border-radius: 16px;
            margin-bottom: 30px;
            position: relative;
            overflow: hidden;
        }

        .module-header::before {
            content: '';
            position: absolute;
            top: 0;
            right: 0;
            width: 300px;
            height: 300px;
            background: radial-gradient(circle, rgba(255, 255, 255, 0.1) 0%, transparent 70%);
            transform: translate(100px, -100px);
        }

        .module-header::after {
            content: '';
            position: absolute;
            bottom: 0;
            left: 0;
            width: 100%;
            height: 4px;
            background: linear-gradient(90deg, #B8860B, #D4A84B, #B8860B);
        }

        .module-label {
            margin: 0;
            font-size: 11px;
            color: rgba(255, 255, 255, 0.75);
            text-transform: uppercase;
            letter-spacing: 2.5px;
            font-weight: 500;
        }

        .lesson-title {
            margin: 10px 0 0 0;
            font-size: 28px;
            color: #ffffff;
            font-weight: 700;
            line-height: 1.3;
            position: relative;
        }

        .lesson-meta {
            display: flex;
            gap: 12px;
            margin-top: 20px;
            padding-top: 18px;
            border-top: 1px solid rgba(255, 255, 255, 0.15);
            flex-wrap: wrap;
        }

        .meta-item {
            display: flex;
            align-items: center;
            gap: 6px;
            font-size: 12px;
            color: rgba(255, 255, 255, 0.85);
            background: rgba(255, 255, 255, 0.1);
            padding: 5px 12px;
            border-radius: 4px;
        }

        /* Table of Contents */
        .toc-box {
            background: linear-gradient(135deg, #fafafa 0%, #f5f5f5 100%);
            border-radius: 14px;
            padding: 24px 28px;
            margin-bottom: 35px;
            border: 1px solid #e8e8e8;
        }

        .toc-box .box-label {
            font-weight: 600;
            color: #b91c1c;
            margin: 0 0 18px 0;
            font-size: 12px;
            text-transform: uppercase;
            letter-spacing: 2px;
            padding-bottom: 12px;
            border-bottom: 1px solid #e0e0e0;
        }

        .toc-list {
            list-style: none;
            margin: 0;
            padding: 0;
            display: grid;
            grid-template-columns: repeat(2, 1fr);
            gap: 8px 24px;
        }

        .toc-list li {
            margin: 0;
        }

        .toc-list a {
            display: flex;
            align-items: center;
            padding: 8px 12px;
            color: #555;
            text-decoration: none;
            font-size: 14px;
            border-radius: 6px;
            transition: all 0.2s ease;
        }

        .toc-list a:hover {
            background: white;
            color: #b91c1c;
            box-shadow: 0 2px 8px rgba(0, 0, 0, 0.06);
        }

        .toc-list .section-num {
            display: inline-flex;
            align-items: center;
            justify-content: center;
            width: 26px;
            height: 26px;
            background: #b91c1c;
            color: white;
            font-weight: 600;
            font-size: 11px;
            border-radius: 6px;
            margin-right: 12px;
            flex-shrink: 0;
        }

        @media (max-width: 600px) {
            .toc-list {
                grid-template-columns: 1fr;
            }
        }

        /* Learning Objectives */
        .objectives-box {
            background: #fef2f2;
            border: 2px solid #ef4444;
            border-radius: 14px;
            padding: 30px 35px;
            margin-bottom: 40px;
        }

        .objectives-box .box-label {
            font-weight: 600;
            color: #b91c1c;
            margin: 0 0 18px 0;
            font-size: 13px;
            text-transform: uppercase;
            letter-spacing: 2px;
            display: flex;
            align-items: center;
            gap: 10px;
        }

        .objectives-box .box-label::before {
            content: 'ðŸŽ¯';
            font-size: 18px;
        }

        .objectives-box ul {
            margin: 0;
            padding-left: 22px;
        }

        .objectives-box li {
            margin-bottom: 14px;
            font-size: 16px;
            line-height: 1.7;
        }

        /* Key Terms Box */
        .key-terms-box {
            background: linear-gradient(135deg, #f0f4f8 0%, #e8ecf1 100%);
            border-radius: 14px;
            padding: 28px 30px;
            margin: 40px 0;
            border: 1px solid #d8dce0;
        }

        .key-terms-box .box-label {
            font-weight: 600;
            color: #b91c1c;
            margin: 0 0 18px 0;
            font-size: 13px;
            text-transform: uppercase;
            letter-spacing: 2px;
        }

        .terms-grid {
            display: grid;
            grid-template-columns: repeat(auto-fit, minmax(280px, 1fr));
            gap: 16px;
        }

        .term-item {
            background: white;
            padding: 16px 18px;
            border-radius: 10px;
            border-left: 4px solid #ef4444;
        }

        .term-item .term {
            font-weight: 700;
            color: #b91c1c;
            font-size: 15px;
            margin: 0 0 6px 0;
        }

        .term-item .definition {
            font-size: 14px;
            color: #555;
            margin: 0;
            line-height: 1.6;
        }

        /* Section Headings */
        h2 {
            font-size: 24px;
            color: #7f1d1d;
            margin: 50px 0 20px 0;
            font-weight: 600;
            position: relative;
            padding-bottom: 12px;
        }

        h2::after {
            content: '';
            position: absolute;
            bottom: 0;
            left: 0;
            width: 60px;
            height: 3px;
            background: #B8860B;
        }

        /* Paragraphs */
        p {
            font-size: 17px;
            margin-bottom: 20px;
            color: #333;
        }

        /* Highlights */
        .highlight {
            background: linear-gradient(180deg, transparent 60%, #ffe4e6 60%);
            padding: 0 4px;
            font-weight: 500;
        }

        /* Welcome/Intro Box */
        .welcome-box {
            background: linear-gradient(135deg, #fff1f2 0%, #ffe4e6 100%);
            padding: 30px 35px;
            border-radius: 14px;
            margin-bottom: 40px;
            border: 1px solid #fecdd3;
        }

        .welcome-box h3 {
            margin: 0 0 15px 0;
            font-size: 20px;
            color: #991b1b;
            font-weight: 600;
        }

        /* Alert Boxes */
        .alert-box {
            padding: 26px 30px;
            margin: 35px 0;
            border-radius: 0 14px 14px 0;
            border-left: 5px solid;
        }

        .alert-box .alert-label {
            font-weight: 600;
            margin: 0 0 12px 0;
            font-size: 12px;
            text-transform: uppercase;
            letter-spacing: 2px;
        }

        .alert-box.warning {
            background: #fff8e6;
            border-left-color: #ff9800;
        }

        .alert-box.warning .alert-label {
            color: #e65100;
        }

        /* Case Study Box */
        .case-study {
            background: linear-gradient(135deg, #f8f9fb 0%, #f0f2f5 100%);
            border-radius: 16px;
            padding: 0;
            margin: 40px 0;
            overflow: hidden;
            box-shadow: 0 4px 20px rgba(0, 0, 0, 0.06);
        }

        .case-study-header {
            background: linear-gradient(135deg, #7f1d1d 0%, #b91c1c 100%);
            padding: 20px 30px;
            display: flex;
            align-items: center;
            gap: 15px;
        }

        .case-study-icon {
            width: 45px;
            height: 45px;
            background: rgba(255, 255, 255, 0.15);
            border-radius: 10px;
            display: flex;
            align-items: center;
            justify-content: center;
            font-size: 22px;
        }

        .case-study-header .box-label {
            font-weight: 600;
            color: #ffffff;
            margin: 0;
            font-size: 16px;
        }

        .case-study-content {
            padding: 28px 30px;
        }

        .patient-profile {
            display: flex;
            align-items: center;
            gap: 18px;
            padding: 18px 22px;
            background: white;
            border-radius: 12px;
            margin-bottom: 20px;
            border: 1px solid #e5e5e5;
        }

        .patient-avatar {
            width: 55px;
            height: 55px;
            background: linear-gradient(135deg, #ef4444, #b91c1c);
            border-radius: 50%;
            display: flex;
            align-items: center;
            justify-content: center;
            font-size: 24px;
            color: white;
            flex-shrink: 0;
        }

        /* Statistics Box */
        .stats-box {
            background: linear-gradient(135deg, #7f1d1d 0%, #b91c1c 100%);
            padding: 40px;
            border-radius: 16px;
            margin: 35px 0;
            position: relative;
            overflow: hidden;
        }

        .stat-number {
            font-size: 42px;
            font-weight: 700;
            color: white;
            line-height: 1;
            margin-bottom: 8px;
        }

        .stat-label {
            font-size: 13px;
            color: rgba(255, 255, 255, 0.85);
            text-transform: uppercase;
            letter-spacing: 1px;
        }

        /* Check Understanding Box */
        .check-understanding {
            background: linear-gradient(135deg, #fdfbf7 0%, #f9f5ed 100%);
            border: 2px solid #B8860B;
            border-radius: 16px;
            padding: 32px;
            margin: 45px 0;
        }

        .question-item {
            background: white;
            border-radius: 12px;
            padding: 22px 24px;
            margin-bottom: 16px;
            border: 1px solid #e8e4dc;
            position: relative;
        }

        .reveal-btn {
            background: #b91c1c;
            color: white;
            border: none;
            padding: 10px 20px;
            border-radius: 8px;
            cursor: pointer;
        }

        .answer-text {
            display: none;
            font-size: 14px;
            color: #7f1d1d;
            margin: 14px 0 0 0;
            padding: 14px;
            background: #fef2f2;
            border-radius: 8px;
        }

        .answer-text.show {
            display: block;
        }

        /* Comparison Table */
        .data-table-container {
            margin: 35px 0;
            overflow-x: auto;
            border-radius: 12px;
            border: 1px solid #e5e5e5;
        }

        table {
            width: 100%;
            border-collapse: collapse;
            font-size: 15px;
        }

        th {
            background: #f1f5f9;
            padding: 15px;
            text-align: left;
            font-weight: 600;
            border-bottom: 2px solid #e2e8f0;
        }

        td {
            padding: 15px;
            border-bottom: 1px solid #f1f5f9;
        }

        /* Takeaways */
        .takeaways-box {
            background: #f8fafc;
            padding: 25px;
            margin-top: 35px;
            border-radius: 12px;
            border: 1px solid #e2e8f0;
        }

        .references-box {
            margin-top: 40px;
            padding-top: 25px;
            border-top: 1px solid #eee;
            font-size: 14px;
            color: #666;
        }

        /* Footer */
        .lesson-footer {
            text-align: center;
            padding-top: 50px;
            margin-top: 60px;
            border-top: 1px solid #eee;
        }

        .footer-logo {
            max-width: 140px;
            opacity: 0.9;
        }
    </style>
</head>

<body>
    <div class="lesson-container">
        <div class="brand-header">
            <img src="/logoimg/LOGO_ACCREDI.png" alt="AccrediPro Academy" class="brand-logo">
        </div>

        <header class="module-header">
            <p class="module-label">Module 11: Clinical Safety & Toxicology</p>
            <h1 class="lesson-title">Lesson 11.5: Adverse Event Reporting and Clinical Documentation</h1>
            <div class="lesson-meta">
                <span class="meta-item">35 min read</span>
                <span class="meta-item">Lesson 5 of 6</span>
            </div>
        </header>

        <div class="toc-box">
            <p class="box-label">In This Lesson</p>
            <ul class="toc-list">
                <li><a href="#section1"><span class="section-num">1</span>The Duty of Documentation</a></li>
                <li><a href="#section2"><span class="section-num">2</span>Defining Adverse Events (AEs)</a></li>
                <li><a href="#section3"><span class="section-num">3</span>The Naranjo Causality Scale</a></li>
                <li><a href="#section4"><span class="section-num">4</span>Standardized Reporting Systems</a></li>
                <li><a href="#section5"><span class="section-num">5</span>SOAP Notes & V.I.T.A.L. Method</a></li>
                <li><a href="#section6"><span class="section-num">6</span>Legal and Ethical Safeguards</a></li>
            </ul>
        </div>

        <div class="objectives-box">
            <p class="box-label">Learning Objectives</p>
            <ul>
                <li>Master the clinical standards for documenting herbal protocols and client responses.</li>
                <li>Differentiate between side effects, idiosyncratic reactions, and drug-herb interactions.</li>
                <li>Utilize the Naranjo Algorithm to assess causality in suspected adverse events.</li>
                <li>Implement standardized reporting procedures for national pharmacovigilance databases.</li>
                <li>Apply the V.I.T.A.L. Methodâ„¢ specifically to Toxicological & Safety Screening (Step T).</li>
            </ul>
        </div>

        <div class="welcome-box">
            <h3>The Practitioner's Shield</h3>
            <p>In the realm of clinical herbalism, your expertise is only as reliable as your documentation. Clinical safety is not merely about preventing harm; it is about the systematic tracking, analysis, and reporting of how botanicals interact with human physiology. This lesson bridges the gap between traditional wisdom and modern medical accountability, ensuring you operate at the highest professional standard of <span class="highlight">pharmacovigilance</span>.</p>
        </div>

        <h2 id="section1">The Duty of Documentation</h2>
        <p>In a clinical setting, the phrase "if it wasn't documented, it didn't happen" is a fundamental legal reality. As a practitioner, your documentation serves three primary purposes: clinical continuity, legal protection, and contribution to the broader scientific understanding of herbal safety. When we apply the <span class="highlight">V.I.T.A.L. Methodâ„¢</span>, the "T" (Toxicological & Safety Screening) requires a written audit trail of every safety check performed.</p>
        
        <p>A 2021 systematic review of herbal safety monitoring found that while adverse events (AEs) from herbal medicines are statistically rare compared to pharmaceuticals, they are significantly <span class="highlight">under-reported</span>. This lack of data hinders our ability to identify rare but serious risks, such as herb-induced liver injury (HILI). By maintaining meticulous records, you act as a critical link in the global safety network.</p>

        <div class="stats-box">
            <div class="stats-grid" style="display: grid; grid-template-columns: repeat(auto-fit, minmax(140px, 1fr)); gap: 25px;">
                <div class="stat-item">
                    <div class="stat-number">~10%</div>
                    <div class="stat-label">AEs Reported to FDA</div>
                </div>
                <div class="stat-item">
                    <div class="stat-number">40%</div>
                    <div class="stat-label">Clients Hide Herbal Use</div>
                </div>
                <div class="stat-item">
                    <div class="stat-number">25k+</div>
                    <div class="stat-label">ER Visits/Year (Supplements)</div>
                </div>
                <div class="stat-item">
                    <div class="stat-number">100%</div>
                    <div class="stat-label">Legal Requirement</div>
                </div>
            </div>
        </div>

        <h2 id="section2">Defining Adverse Events (AEs)</h2>
        <p>To report effectively, you must understand what qualifies as an adverse event. An <span class="highlight">Adverse Event (AE)</span> is any untoward medical occurrence in a patient administered a medicinal product, which does not necessarily have a causal relationship with the treatment. This is distinct from an <span class="highlight">Adverse Drug Reaction (ADR)</span>, where a causal relationship is at least a reasonable possibility.</p>

        <div class="data-table-container">
            <table>
                <thead>
                    <tr>
                        <th>Type of Reaction</th>
                        <th>Mechanism</th>
                        <th>Predictability</th>
                        <th>Example</th>
                    </tr>
                </thead>
                <tbody>
                    <tr>
                        <td><strong>Type A (Augmented)</strong></td>
                        <td>Dose-dependent, pharmacological action</td>
                        <td>Predictable</td>
                        <td>Loose stools from high-dose Magnesium or Senna</td>
                    </tr>
                    <tr>
                        <td><strong>Type B (Bizarre)</strong></td>
                        <td>Idiosyncratic or Immunological (Allergy)</td>
                        <td>Unpredictable</td>
                        <td>Anaphylaxis from Chamomile (Asteraceae allergy)</td>
                    </tr>
                    <tr>
                        <td><strong>Type C (Chronic)</strong></td>
                        <td>Cumulative dose over time</td>
                        <td>Predictable with monitoring</td>
                        <td>Hepatotoxicity from long-term Pyrrolizidine Alkaloids</td>
                    </tr>
                    <tr>
                        <td><strong>Type D (Delayed)</strong></td>
                        <td>Carcinogenesis or Teratogenesis</td>
                        <td>Very difficult to predict</td>
                        <td>Fetal malformation from contraindicated herbs</td>
                    </tr>
                </tbody>
            </table>
        </div>

        <h2 id="section3">The Naranjo Causality Scale</h2>
        <p>When a client reports a symptom after starting a formula, how do you know the herb caused it? The <span class="highlight">Naranjo Algorithm</span> is a validated 10-question scale used to determine the probability that an adverse event was caused by a specific substance rather than other factors (like underlying disease or concurrent medication).</p>

        <div class="alert-box warning">
            <p class="alert-label">Clinical Tool: The Naranjo Questions</p>
            <p>1. Are there previous conclusive reports on this reaction?<br>
            2. Did the adverse event appear after the herb was administered?<br>
            3. Did the reaction improve when the herb was discontinued?<br>
            4. Did the reaction reappear when the herb was readministered?<br>
            5. Are there alternative causes (other than the herb)?</p>
        </div>
        
        <p>Scoring: A total score of 9+ indicates a "Definite" causal relationship; 5-8 is "Probable"; 1-4 is "Possible"; and 0 is "Doubtful." In your clinical notes, you should document the Naranjo score whenever a serious AE occurs.</p>

        <div class="case-study">
            <div class="case-study-header">
                <div class="case-study-icon">ðŸ“‹</div>
                <div>
                    <p class="box-label">Case Study: The "Possible" Interaction</p>
                    <p style="color: rgba(255,255,255,0.8); margin:0; font-size:12px;">Pharmacovigilance in Practice</p>
                </div>
            </div>
            <div class="case-study-content">
                <div class="patient-profile">
                    <div class="patient-avatar">JD</div>
                    <div class="patient-info">
                        <h4>James D., 54</h4>
                        <p>Presenting: Hypertension, Mild Anxiety</p>
                    </div>
                </div>
                <p><strong>Intervention:</strong> Practitioner prescribed a formula containing Hawthorn (<em>Crataegus spp.</em>) and Motherwort (<em>Leonurus cardiaca</em>). James was already taking Lisinopril (an ACE inhibitor).</p>
                <p><strong>Incident:</strong> On day 4, James reported dizziness and a "fluttering" sensation. Blood pressure reading was 95/60 mmHg (Hypotension).</p>
                <p><strong>Causality Assessment:</strong> Using Naranjo, the score was 6 (Probable). The dizziness appeared after administration (+2), improved upon cessation (+1), and there were previous reports of Hawthorn potentiating hypotensive drugs (+1).</p>
                <p><strong>Outcome:</strong> The practitioner documented the event, discontinued the Hawthorn, and reported the potential interaction to the national database. James's BP stabilized within 24 hours.</p>
            </div>
        </div>

        <h2 id="section4">Standardized Reporting Systems</h2>
        <p>As a professional herbalist, you have an ethical obligation to report serious adverse events to national regulatory bodies. This process, known as <span class="highlight">Spontaneous Reporting</span>, helps identify "safety signals" that may lead to label changes or product recalls.</p>
        
        <ul class="content-list">
            <li><strong>United States:</strong> FDA Safety Reporting Portal (CAERS - CFSAN Adverse Event Reporting System).</li>
            <li><strong>United Kingdom:</strong> The Yellow Card Scheme (MHRA).</li>
            <li><strong>Canada:</strong> MedEffect Canada (Canada Vigilance Program).</li>
            <li><strong>Australia:</strong> Therapeutic Goods Administration (TGA) Incident Reporting.</li>
        </ul>
        
        <p>What should you report? Anything "Serious," defined as: death, life-threatening events, hospitalization, significant disability, or congenital anomalies. You should also report unexpected minor reactions that are not listed in standard pharmacopoeias.</p>

        <h2 id="section5">SOAP Notes & V.I.T.A.L. Methodâ„¢ Integration</h2>
        <p>Clinical documentation should follow the <span class="highlight">SOAP format</span> (Subjective, Objective, Assessment, Plan), but for herbalists, we integrate the <span class="highlight">V.I.T.A.L. Methodâ„¢</span> to ensure botanical specificity.</p>

        <div class="principle-card">
            <p class="principle-title">S - Subjective</p>
            <p class="principle-text">Clientâ€™s self-reported symptoms, energy levels (Vitality), and adherence to the herbal protocol.</p>
        </div>
        <div class="principle-card">
            <p class="principle-title">O - Objective</p>
            <p class="principle-text">Vitals (BP, HR), tongue/pulse assessment, and lab results (e.g., Liver enzymes if monitoring safety).</p>
        </div>
        <div class="principle-card">
            <p class="principle-title">A - Assessment</p>
            <p class="principle-text">The practitioner's analysis. This is where Step T (Toxicological Screening) occurs. You must document: "Safety screening performed for [Herb] and [Drug]; no known contraindications found in ABC/AHPA databases."</p>
        </div>
        <div class="principle-card">
            <p class="principle-title">P - Plan</p>
            <p class="principle-text">The Individualized Formulation (Step I), dosage, duration, and specific "Red Flags" the client was instructed to watch for.</p>
        </div>

        <h2 id="section6">Legal and Ethical Safeguards</h2>
        <p>To minimize liability and maximize safety, every practitioner must utilize <span class="highlight">Informed Consent</span>. This document should explicitly state that herbal medicine is not a substitute for medical diagnosis and that potential side effects, though rare, can occur. </p>
        
        <p>A 2023 legal review of complementary medicine practitioners (n=412 cases) highlighted that the most common cause of disciplinary action was not the treatment itself, but the <span class="highlight">failure to maintain adequate records</span> or the failure to refer a client to a physician when "Red Flags" appeared. Documentation of your referral is your strongest legal defense.</p>

        <div class="check-understanding">
            <p class="box-label">Check Your Understanding</p>
            <p class="box-subtitle">Test your knowledge of clinical safety procedures.</p>
            
            <div class="question-item">
                <div class="question-number">1</div>
                <p class="question-text">A client experiences a rash after taking an Echinacea tincture. They have a known allergy to ragweed. What type of adverse reaction is this, and how would you classify it?</p>
                <button class="reveal-btn" onclick="this.nextElementSibling.classList.toggle('show')">Reveal Answer</button>
                <p class="answer-text">This is a Type B (Bizarre/Idiosyncratic) reaction. Specifically, it is a cross-sensitivity allergic reaction due to Echinacea being in the Asteraceae (Daisy) family. It is unpredictable unless the practitioner identifies the ragweed allergy during the Step T (Toxicological Screening) of the V.I.T.A.L. Methodâ„¢.</p>
            </div>

            <div class="question-item">
                <div class="question-number">2</div>
                <p class="question-text">What is the minimum Naranjo score required to classify a reaction as "Probable"?</p>
                <button class="reveal-btn" onclick="this.nextElementSibling.classList.toggle('show')">Reveal Answer</button>
                <p class="answer-text">A score of 5 to 8 is required for a reaction to be classified as "Probable." Scores of 9 or higher are classified as "Definite."</p>
            </div>
        </div>

        <div class="takeaways-box">
            <p class="box-label">Key Takeaways</p>
            <ul>
                <li><strong>Documentation is Evidence:</strong> Detailed SOAP notes are your primary tool for both client safety and legal defense.</li>
                <li><strong>Use Validated Tools:</strong> The Naranjo Algorithm provides an objective framework for determining if an herb caused a symptom.</li>
                <li><strong>Contribute to Safety:</strong> Reporting serious adverse events to CAERS or the Yellow Card scheme is a professional responsibility.</li>
                <li><strong>V.I.T.A.L. Methodâ„¢ Step T:</strong> Always document the specific databases or texts consulted for safety screenings (e.g., AHPA Botanical Safety Handbook).</li>
                <li><strong>Differentiate Reactions:</strong> Distinguish between dose-dependent side effects (Type A) and unpredictable allergies (Type B).</li>
            </ul>
        </div>

        <div class="references-box">
            <p style="font-weight: 600; color: #333; margin-bottom: 10px;">References & Further Reading</p>
            <p>Naranjo CA, et al. (1981). "A method for estimating the probability of adverse drug reactions." Clinical Pharmacology & Therapeutics.</p>
            <p>Gardiner P, et al. (2021). "The state of herbal safety monitoring: A systematic review of pharmacovigilance." Journal of Ethnopharmacology.</p>
            <p>FDA (2023). "How to Report a Dietary Supplement Adverse Event." CFSAN Safety Portal Guidelines.</p>
            <p>World Health Organization (2022). "WHO guidelines on safety monitoring of herbal medicines in pharmacovigilance systems." WHO Press.</p>
            <p>Sridhar S, et al. (2023). "Legal liabilities and documentation standards for complementary medicine practitioners." Medical Law Review.</p>
            <p>American Herbal Products Association (2021). "Botanical Safety Handbook, 2nd Edition." AHPA/CRC Press.</p>
        </div>

        <footer class="lesson-footer">
            <img src="/logoimg/LOGO_ACCREDI.png" alt="AccrediPro Academy" class="footer-logo">
            <p class="brand">AccrediPro Academy Certification</p>
            <p class="copyright">&copy; 2024 AccrediPro Academy. All Rights Reserved. Professional Herbalism Practitioner Program.</p>
        </footer>
    </div>
</body>

</html>